Outset Medical, Inc.
$4.61
▲
4.43%
2026-04-21 08:37:01
www.outsetmedical.com
NMS: OM
Explore Outset Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$84.32 M
Current Price
$4.61
52W High / Low
$21.98 / $3
Stock P/E
—
Book Value
$6.99
Dividend Yield
—
ROCE
-29.4%
ROE
-1.06%
Face Value
—
EPS
$-5.37
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
310
Beta
1.96
Debt / Equity
79.75
Current Ratio
6.67
Quick Ratio
5.4
Forward P/E
-1.79
Price / Sales
0.64
Enterprise Value
$9.21 M
EV / EBITDA
-0.15
EV / Revenue
0.08
Rating
Strong Buy
Target Price
$10.5
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Lifeward Ltd. | $7.52 | — | $11.49 M | — | -155.52% | -1.46% | $18.6 / $4.14 | $5.52 |
| 2. | Masimo Corporation | $178.4 | 46.03 | $9.34 B | — | 23.57% | 23.43% | $179 / $125.94 | $13.84 |
| 3. | Integer Holdings Corporation | $89.32 | 29.89 | $3.07 B | — | 7.52% | 6.11% | $127.56 / $62 | $50.85 |
| 4. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 5. | electroCore, Inc. | $6.31 | — | $51.01 M | — | -179.71% | -4.79% | $8.64 / $4.16 | $-0.21 |
| 6. | Quanterix Corporation | $3.3 | — | $164.29 M | — | -31.92% | -34.25% | $8.77 / $3.23 | $6.33 |
| 7. | Pulmonx Corporation | $1.42 | — | $59.98 M | — | -49.13% | -77.19% | $5.46 / $1.13 | $1.3 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 28.87 M | 29.43 M | 31.42 M | 29.75 M | 29.47 M | — |
| Operating Profit | -17.63 M | -15.81 M | -16.86 M | -16.4 M | -21.86 M | — |
| Net Profit | -19.49 M | -17.84 M | -18.54 M | -25.78 M | -25.64 M | — |
| EPS in Rs | -1.06 | -0.97 | -1.01 | -1.41 | -1.4 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 119.48 M | 113.69 M | 130.38 M | 115.38 M |
| Operating Profit | -66.71 M | -113.38 M | -169.77 M | -161.02 M |
| Net Profit | -81.65 M | -127.98 M | -172.8 M | -162.96 M |
| EPS in Rs | -4.46 | -6.99 | -9.44 | -8.9 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 264.5 M | 275.8 M | 313.8 M | 400.12 M |
| Total Liabilities | 137.54 M | 248.98 M | 190.91 M | 154.12 M |
| Equity | 126.95 M | 26.82 M | 122.89 M | 245.99 M |
| Current Assets | 250.88 M | 258.22 M | 291.22 M | 373.64 M |
| Current Liabilities | 37.63 M | 45.38 M | 55.32 M | 51.95 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -46.33 M | -116.3 M | -131.37 M | -145.73 M |
| Investing CF | -97.68 M | 103.94 M | 83.03 M | -66.3 M |
| Financing CF | 55.5 M | 67.87 M | 43.65 M | 72.9 M |
| Free CF | -47.12 M | -117.22 M | -134.81 M | -154.05 M |
| Capex | -0.8 M | -0.91 M | -3.44 M | -8.32 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -12.8% | 13% | — | — |
| Earnings Growth % | 25.94% | -6.04% | — | — |
| Profit Margin % | -112.57% | -132.54% | -141.24% | — |
| Operating Margin % | -99.72% | -130.22% | -139.56% | — |
| Gross Margin % | 33.92% | 22.24% | 15.46% | — |
| EBITDA Margin % | -86.1% | -117.96% | -133.41% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-03-20 | 1:0.0666667 |